Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells.
Zhang J, Zhu J, Zheng G, Wang Q, Li X, Feng Y, Shang F, He S, Jiang Q, Shi B, Wang D, Cao Z, Wang J.
Zhang J, et al. Among authors: jiang q.
Front Immunol. 2022 Jan 3;12:811364. doi: 10.3389/fimmu.2021.811364. eCollection 2021.
Front Immunol. 2022.
PMID: 35046962
Free PMC article.